Background
Polycythemia vera (PV) - PV is a rare illness that causes the body to
make too many red blood cells. The most common symptoms of PV are blood
clots, heart attacks and strokes. PV has no known cause. A few studies,
published more than 25 years ago, reported that PV could possibly be
caused by exposure to chemicals (benzene, embalming fluid, petroleum
products) or radiation.
In 2004, a change (mutation) in a gene called JAK2 was found to occur
in most PV patients. This mutation is not inherited and causes bone
marrow cells to constantly make red blood cells – even when the body
signals them to stop. This discovery has now led scientists to search
for the cause of the JAK2 mutation in hopes that this knowledge will
help them find the cause of PV.
ATSDR Investigation
In October 2006, the Pennsylvania Department of Health requested
ATSDR’s help in investigating a high number of PV cases reported in
Carbon, Luzerne, and Schuylkill counties. ATSDR was asked to make sure
that the reported cases actually had PV, and to find any other cases of
PV in the tri-county area. A survey of the possible cases was conducted
to collect information on work and residence histories, health status,
and other factors that might be related to PV. ATSDR’s field work began
in November 2006, and was completed in July 2007. In October 2007, ATSDR
held a community meeting in Hazleton, Pennsylvania to discuss its
findings. ATSDR issued a
news
release summarizing the findings.
ATSDR’s analysis of the data concludes that to date:
- 131 people living in the tri-county area from 2001 to 2005 were
diagnosed with PV or self-reported that they might have PV.
- More than half (52%; 33/64) of the people tested for the JAK2
mutation were confirmed to have it.
- The 33 people with the JAK2 mutation did not share common
occupations, drinking water sources, or other identifiable environmental
exposures.
- The occurrence of PV in the tri-county area during the five year
period 2001-2005 is higher than expected.
- Significant problems exist with correct diagnoses and subsequent
reporting to the state cancer registry within the study area.
- ATSDR continues to analyze these data to determine the geographic
patterns of polycythemia vera, and to identify any risk factors that
might be linked to particular geographical areas. At this time, ATSDR
cannot link polycythemia vera risk with specific environmental exposures
or where patients live.
Current Activities
ATSDR activities in the PV investigation in 2008 include:
- Mapping the home addresses of PV cases at time of diagnosis to
identify census tracts and zip codes with the highest PV rates
- Reviewing environmental data specific to those areas
- Organizing a meeting with research partners to identify and discuss
future research activities
- Planning a public meeting to discuss with the community the study
findings and proposed research activities
- Generating a community report that describes the investigation and
its findings
- Generating a scientific publication that reports the findings from
this investigation and identifies areas for future follow-up and study
Selected Resources for the Reader
Tamaqua Area Cancer Incidence Study Report 1996-2002
Polycythemia Vera (review article in American Family Physician)
JAK2 Mutation Screening for Diagnosis of Polycythemia Vera and Other
Chronic Myeloproliferative Disorders